title: [Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels].
authors.affiliation: Zentrum für Strahlentherapie und Radioonkologie, Mozartstr. 30, 26655, Westerstede, Deutschland. hermann@strahlentherapie-westerstede.com.
authors.forename: R M
authors.initials: RM
authors.lastname: Hermann
authors.affiliation: Klinik für Strahlentherapie und Spezielle Onkologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
authors.forename: H
authors.initials: H
authors.lastname: Christiansen
mesh_terms: D000328:Adult; D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage; D059186:Chemoradiotherapy, Adjuvant / Q000379:methods / Q000401:mortality* / Q000706:statistics & numerical data; D003131:Combined Modality Therapy / Q000379:methods / Q000401:mortality*; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000401:mortality* / Q000706:statistics & numerical data; D011471:Prostatic Neoplasms / Q000097:blood / Q000401:mortality* / Q000628:therapy*; D012307:Risk Factors; D016879:Salvage Therapy / Q000401:mortality* / Q000706:statistics & numerical data; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen